Project information
The roles of Cdk12 in ovarian tumorigenesis

Project Identification
MRF2013
Project Period
4/2013 - 3/2014
Investor / Pogramme / Project type
Ostatní - foreign
MU Faculty or unit
Central European Institute of Technology

Comprehensive genomic analyses of patient samples revealed
virtually unstudied cyclin-dependent kinase 12 (Cdk12) as a novel
candidate in ovarian tumorigenesis. Our recent study determined that Cdk12
maintains genome stability via regulation of transcription of key
DNA-damage response genes including BRCA1, ATR and FANCI; pointing this
kinase to be a novel tumor suppressor and a potential drug target.
However, precise molecular mechanisms leading to the Cdk12-dependent
ovarian tumorigenesis are unknown. The goal of this project is to achieve
an initial molecular understanding of these deregulations; this could
eventually lead to development of novel therapeutic approaches for ovarian
cancer.

You are running an old browser version. We recommend updating your browser to its latest version.

More info